INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 519
28/07/2017
Comentaris i suggeriments
Banner-noves-convocatories-02
Cercador de convocatòries
Projectes
Termini exhaurit
INNOVATIVE MEDICINES INITIATIVE
IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.
 
Termini exhaurit
INNOVATIVE MEDICINES INITIATIVE
IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.
 
Termini exhaurit
FUNDACION MAPFRE MEDICINA
 
Borses de viatge
Termini exhaurit
FUNDACIÓ ACADÈMIA DE CIÈNCIES MÈDIQUES I DE LA SALUT DE CATALUNYA I BALEARS
Proporcionar als residents en últim any de l’especialitat d’Oncologia Radioteràpica o als especialistes en Oncologia Radioteràpica, l’oportunitat d’ampliar o d’actualitzar la seva formació tant clínica com de recerca a un o més centres de l’estranger.
 
Premis
Termini exhaurit
HOSPITAL SAN RAFAEL DE LA CORUÑA
Premiar el millor treball sobre innovacions de l'endoscòpia digestiva en el diagnòstic i tractament de tumors.
 
Termini exhaurit
FPdGI - FUNDACIÓ PRINCESA DE GIRONA
Dirigida a premiar la trajectòria de joves científics (incloent de les ciències humanes i socials) amb experiències o projectes d'investigació destacats en la seva disciplina, emprenedors, innovadors i amb un elevat potencial de desenvolupament futur.
 
Termini exhaurit
MSCBS - MINISTERIO DE SANIDAD
El Ministeri de Sanitat i Política Social pretén impulsar les iniciatives que s'emmarquin en els seus objectius bàsics de prevenir l'obesitat i altres malalties cròniques derivades, a través d'una alimentació saludable i la pràctica regular d'activitat física.
 
Recursos Humans
Termini exhaurit
FUNDACION MAPFRE MEDICINA
Es convoquen 10 ajuts a la recerca amb l'objecte de facilitar suport econòmic per a la realització de projectes d'investigació en les següents àrees: Promoció de la Salut i Assegurança i Previsió Social.

Les àrees i línies temàtiques sobre les que han de versar els projectes d'investigació són les següents:

Àrea de Promoció de la Salut:
  • Estratègies per al canvi d'hàbits: prevenció de l'obesitat i foment de l'activitat física.
  • Educació per a pacients.
  • Valoració del dany corporal.
  • Gestió sanitària: qualitat i seguretat clínica.

    Assegurança i Previsió Social: Els desafiaments del segle XXI
  • L'assegurança
  • Previsió social
    		•
     
    Termini exhaurit
    FEHH - FUNDACION ESPAÑOLA DE HEMATOLOGIA Y HEMOTERAPIA
    Convocar un programa de 9 beques per al próxim curs 2017-2018 (7 beques de la FEHH i 2 beques d'una col·laboració FEHH-Janssen. Les beques van dirigides a socis numeraris de la Societat Espanyola d'Hematologia i Hemoteràpia que vulguin fer un projecte de recerca en un centre espanyol, en l'àmbit de les àrees que conformen l'especialitat d'Hematologia i Hemoteràpia.
     
    Termini exhaurit
    ACCIÓ
    TECNIOspring PLUS és un programa de beques de mobilitat internacional que ofereix als investigadors experimentats la possibilitat de desenvolupar la seva carrera investigadora en qualsevol entitat d'R + D al món.
     
     
     
    Informació últil
     
     
     
    Banner-convocatories-tancament-02
    Projectes
    Termini exhaurit
    COMISSIÓ EUROPEA
    Advanced Grants are designed to support excellent Principal Investigators at the career stage at which they are already established research leaders with a recognised track record of research achievements. Applicant Principal Investigators must demonstrate the ground-breaking nature, ambition and feasibility of their scientific proposal.
     
    Termini exhaurit
    AECC Catalunya - ASSOCIACIÓ ESPANYOLA CONTRA EL CÁNCER DE CATALUNYA
    Aquests ajuts estan destinats a persones professionals i investigadores d’àrees relacionades amb l’oncologia per desenvolupar un projecte de recerca en un centre que pertany a Barcelona i les seves comarques per potenciar la recerca oncològica dels equips de grups emergents.
    Aquest ajut és incompatible amb qualsevol altre ajut ACTIU concedit per la Fundació AECC o per l’AECC. L’in-compliment d’aquest requisit comportarà l’anul·lació au-tomàtica de l’ajuda, i la Junta Provincial de l’aecc de Bar-celona podrà reclamar la totalitat dels imports lliurats.
     
    Termini exhaurit
    MINECO - MINISTERIO DE ECONOMÍA Y COMPETITIVIDAD
    Finançar projectes de recerca col·laborativa de dimensió europea i internacional.
    Es pretén finançar la part espanyola de projectes col·laboratius que hagin concurregut a convocatòries internacionals conjuntes, en àrees temàtiques específiques, i que demostrin un valor afegit de la col·laboració internacional a l'hora d'enfrentar-se als reptes de la societat.
     
    Termini exhaurit
    EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
    The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide multiple funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.
     
    Termini exhaurit
    DANONE INSTITUTE INTERNATIONAL
    Proposals are requested for projects focused on health benefits associated with yogurt consumption. Research focused in the following areas are particularly encouraged:
  • mechanism of action,
  • biological effects of yogurt live ferments & fermentation products
  • impact of yogurt consumption on gut microbiota
  • in adults and in children
    The grant is supported by Danone Institute International in collaboration with the American Society for Nutrition (ASN) and the International Osteoporosis Foundation (IOF)
    		•
     
    Termini exhaurit
    DEPARTMENT OF DEFENSE
    The mission of the FY17 PCRP is to find and fund research that will lead to the elimination of death from prostate cancer and enhance the well-being of men experiencing the impact of the disease. Specifically, the PCRP seeks to promote highly innovative, groundbreaking research; high-impact research with near-term clinical relevance; multidisciplinary, synergistic research; translational studies to support the fluid transfer of knowledge between bench and bedside; research on patient survivorship and quality of life; the next generation of prostate cancer investigators through mentored research; and research on disparities in the incidence and mortality of prostate cancer.
     
    Termini exhaurit
    BAYER
    Bayer's mission is to provide new treatment options for diseases with high unmet medical need.
    Bayer HealthCare allocates grants for the exploration of attractive, novel drug targets in the fields of: Oncology, Gynecology, Cardiology and Hematology.
     
    Altres
    Termini exhaurit
    INTERNATIONAL BRAIN RESEARCH ORGANIZATION (IBRO)
    IBRO is a union of neuroscience organizations with the aim to promote and support neuroscience training and collaborative research around the world.

    With the aim to foster cooperation among young European neuroscientists, IBRO-PERC awards partial funding for Meetings, Workshops and Symposia on important topics in neuroscience organized in European countries taking place between October 1st, 2017 and March 30th, 2018. Preference is given to activities that include younger scientists and offer training for scientists from countries with limited resources for research or teaching.
     
    Termini exhaurit
    THE COMPANY OF BIOLOGISTS
    The Company of Biologists' journals – Development, Journal of Cell Science, The Journal of Experimental Biology, and Disease Models & Mechanisms (DMM) – will consider applications for a grant towards the cost of running a small meeting within the fields of our journals. This would normally be a small budget, local meeting.
     
    Termini exhaurit
    THE COMPANY OF BIOLOGISTS
    The Company of Biologists' journals – Development, Journal of Cell Science, The Journal of Experimental Biology, and Disease Models & Mechanisms (DMM) – consider funding requests from the organisers of a range of charitable activities including – but not limited to meetings -workshops and conferences in the fields covered by our journals. Organisers may use a grant from The Company of Biologists in a variety of ways, for example to meet the expenses of a plenary or keynote speaker, assist with travel for early career scientists, or to reduce (or waive) registration fees.
     
    Borses de viatge
    Termini exhaurit
    FSEMI - FUNDACIÓN SOCIEDAD ESPAÑOLA DE MEDICINA INTERNA
    Ajudes per a realitzar estades formatives en centres situats a l'estranger.
     
    Termini exhaurit
    JSPS - JAPAN SOCIETY FOR PROMOTION OF SCIENCE (JSPS)
    The Japan Society for the Promotion of Science (JSPS) carries out programs that provide overseas researchers who have an excellent record of research achievements with an opportunity to conduct collaborative research, discussions, and opinion exchanges with researchers in Japan. These programs are intended to help advance the overseas researchers' research activities while promoting science and internationalization in Japan.
     
    Termini exhaurit
    JSPS - JAPAN SOCIETY FOR PROMOTION OF SCIENCE (JSPS)
    The Japan Society for the Promotion of Science (JSPS) carries out programs that provide overseas researchers who have an excellent record of research achievements with an opportunity to conduct collaborative research, discussions, and opinion exchanges with researchers in Japan. These programs are intended to help advance the overseas researchers' research activities while promoting science and internationalization in Japan.
     
    Termini exhaurit
    DAAD - DEUTSCHER AKADEMISCHER AUSTAUSCH DIENST
     
    Termini exhaurit
    DAAD - DEUTSCHER AKADEMISCHER AUSTAUSCH DIENST
     
    Premis
    Termini exhaurit
    AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
    The award is given to an individual whose leadership and extraordinary achievements in cancer research or in support of cancer research have made a major impact on the field. Such achievements include contributions to the acceleration of progress in cancer research, raising national or international awareness of cancer research, or other demonstrations of a sustained commitment to the conquest of cancer.
     
    Termini exhaurit
    AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
    This lectureship will recognize an individual scientist whose novel and significant work has had or may have a far-reaching impact on the detection, diagnosis, treatment, or prevention of cancer.
     
    Termini exhaurit
    AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
    The AACR and the American Cancer Society established this award in 1992 to honor outstanding research accomplishments in the fields of cancer epidemiology, biomarkers, and prevention.
     
    Termini exhaurit
    ASCI - American Society for Clinical Investigation
    The American Society for Clinical Investigation (ASCI) established in 1908, is one of the nation's oldest and most respected medical honor societies. The ASCI is dedicated to the advancement of research that extends the understanding and improves the treatment of human diseases, and its members are committed to mentoring future generations of physician-scientists.

    The Harrington Discovery Institute at University Hospitals Case Medical Center, part of a national initiative unveiled in February 2012 called the Harrington Project, is a nonprofit medical institute dedicated to physician-scientists, enabling them to transform breakthrough insights into novel therapies that enhance patient care. The Harrington Project is fueled by $250 million in donations and other funding, including $50 million from the Harrington Family.
     
    Recursos Humans
    Termini exhaurit
    HUMAN FRONTIER SCIENCE PROGRAMME

    The Human Frontier Science Program Organization (HFSPO) supports innovative basic research into fundamental biological problems, with emphasis placed on novel approaches that cross disciplinary boundaries.

    Long-Term Fellowships (LTF) are for applicants with a Ph.D. in a biological discipline, who will broaden their expertise by proposing a project in the life sciences which is significantly different from their previous Ph.D. or postdoctoral work.

    Cross-Disciplinary Fellowships (CDF) are for applicants with a Ph.D. from outside the life sciences (e.g. in physics, chemistry, mathematics, engineering or computer sciences), who have not worked in biological fields before.

    The HFSP fellowship program funds innovative, ground-breaking projects that have the potential to advance knowledge in the applicants’ field of study or open a new approach to a research problem. High risk research is supported.
     
    Termini exhaurit
    JSPS - JAPAN SOCIETY FOR PROMOTION OF SCIENCE (JSPS)
    The Japan Society for the Promotion of Science (JSPS) carries out programs that provide overseas researchers who have an excellent record of research achievements with an opportunity to conduct collaborative research, discussions, and opinion exchanges with researchers in Japan. These programs are intended to help advance the overseas researchers' research activities while promoting science and internationalization in Japan.
     
    Termini exhaurit
    JSPS - JAPAN SOCIETY FOR PROMOTION OF SCIENCE (JSPS)
    The Japan Society for the Promotion of Science (JSPS) carries out programs that provide overseas researchers who have an excellent record of research achievements with an opportunity to conduct collaborative research, discussions, and opinion exchanges with researchers in Japan. These programs are intended to help advance the overseas researchers' research activities while promoting science and internationalization in Japan.
     
    Termini exhaurit
    MATSUMAE INTERNATIONAL FOUNDATION
    The Matsumae International Foundation awards about 20 fellowships for post-doctoral stays in Japan.
     
     
     
     
    Articles
     
    García-Martínez P*, Curto-Barredo L, Rovira-López R, Pujol RM. Multiple Epidermolytic Acanthomas on the Scrotum: What Genital Pruritus Can Reveal. Actas Dermosifiliograf 2018; 109(1): 81-82.
     
    Soriano Tàrrga C, Mola M, Giralt E, Ois A, Rodríguez Campello A, Cuadrado E, Gómez-González A, Vivanco R, Fernández-Cadenas I, Cullell N, Roquer González J*, Jiménez Conde J*. Biological age is better than chronological as predictor of 3-month outcome in ischemic stroke. Neurology 2017; 89(8): 830-836.
     
    Mangold AR*, Thompson AK, Davis MD, Saulite I, Cozzio A, Guenova E, Hodak E, Amitay-Laish I, Pujol RM, Pittelkow MR, Gniadecki R. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study. J Am Acad Dermatol 2017; 77(4): 719-727.
     
    Cantero I, Abete I, Babio N, Arós F, Corella D, Estruch Riba R, Fitó Colomer M, Hebert JR, Martínez González M.A, Pintó X, Puy-Portillo M, Ruiz Canela M, Shivappa N, Wärnberg J, Gómez Gracia E, Tur J.A, Salas Salvadó J, Zulet MA*, Martínez J.A. Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trial. Clin Nutr 2018; 37(5): 1736-1743.
     
    Rosellini AJ, Liu H, Petukhova MV, Sampson NA, Aguilar-Gaxiola S, Alonso J, Borges G, Bruffaerts R, Bromet EJ, de Girolamo G, de Jonge, Fayyad J, Florescu S, Gureje O, Haro JM, Hinkov H, Karam EG, Kawakami N, Koenen KC, Lee S, Lépine JP, Levinson D, Navarro-Mateu F, Oladeji BD, O'Neill S, Pennell BE, Piazza M, Posada-Villa J, Scott KM, Stein DJ, Torres Y, Viana MC, Zaslavsky AM, Kessler RC*. Recovery from DSM-IV post-traumatic stress disorder in the WHO World Mental Health surveys. Psychol Med 2018; 48(3): 437-450.
     
    Burgos J, Hernández-Losa J, Landolfi S, Guelar A, Dinares M, Villar J, Navarro J, Ribera E, Falcó V, Curran A. The role of oncogenic human papillomavirus determination for diagnosis of high-grade anal intraepithelial neoplasia in HIV-infected MSM. AIDS 2017; 31(16): 2227-2233.
     
    Galar A*, Valerio M, Muñoz P, Alcalá L, García-González X, Burillo A, Sanjurjo M, Grau S, Bouza E*. Systematic Therapeutic Drug Monitoring for Linezolid: Variability and Clinical Impact. Antimicrob Agents Chemother 2017; 61(10): e00687-17.
     
    Fernández de Larrea-Baz N*, Michel A, Romero B, Butt J, Pawlita M, Pérez Gómez B, Castaño Vinyals G, Moreno V, Martín V, Amiano P, Castilla J, Fernández Tardón G, Dierssen-Sotos T, Clofent J, Alguacil J, Huerta JM, Jiménez-Moleón JJ, Barricarte A, Molinuevo A, Fernández-Villa T, Casabonne D, Sierra Á, Kogevinas M, de Sanjosé S, Pollán M, Del Campo R, Waterboer T, Aragonés Sanz N. Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013. Helicobacter 2017; 22(5): e12401.
     
    Climent E, Pérez-Calahorra S, Marco-Benedí V, Plana N, Sánchez R, Ros E, Ascaso JF, Puzo J, Almagro F, Lahoz C, Civeira F, Pedro-Botet J*. Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia. Sci Rep 2017; 7: 5596.
     
    Garcia-Martínez I, Sánchez-Mora C, Soler M, Rovira P, Pagerols M, Corrales M, Calvo-Sánchez E, Richarte V, Bustamante M, Sunyer J, Cormand B*, Casas M, Ramos-Quiroga JA, Ribasés M*. Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder. Sci Rep 2017; 7: 5407.
     
    Rubio-Pérez C, Guney E, Aguilar D, Piñero J, García-García J, Iadarola B, Sanz F*, Fernandez-Fuentes N*, Furlong LI*, Oliva B*. Genetic and functional characterization of disease associations explains comorbidity. Sci Rep 2017; 7: 6207.
     
    Ibáñez L*, del Rio L, Díaz M, Sebastiani G, Pozo O, López-Bermejo A, de Zegher. Normalizing Ovulation Rate by Preferential Reduction of Hepato-Visceral Fat in Adolescent Girls With Polycystic Ovary Syndrome. J Adolesc Health 2017; 61(4): 446-453.
     
    Reyes C, Tebe C, Martinez-Laguna D, Ali MS, Soria-Castro A, Carbonell C, Prieto-Alhambra D*. One and two-year persistence with different anti-osteoporosis medications: a retrospective cohort study. Osteoporosis Int 2017; 28(10): 2997-3004.
     
    Martinez-Laguna D, Nogués X, Abrahamsen B, Reyes C, Carbonell-Abella C, Díez-Pérez A, Prieto-Alhambra D*. Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study. Osteoporosis Int 2017; 28(9): 2573-2581.
     
    Hidalgo-Mazzei D, Reinares M, Mateu A, Juruena MF, Young AH, Pérez V, Vieta E*, Colom F. Is a SIMPLe smartphone application capable of improving biological rhythms in bipolar disorder?. J Affect Disorders 2017; 223: 10-16.
     
    Kuypers KPC*, de la Torre R, Farré M, Pizarro N, Xicota L, Ramaekers JG. MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor. Psychopharmacology 2018; 235(2): 481-490.
     
    Navarro-Mateu F*, Salmerón D, Vilagut G, Tormo MJ, Ruíz-Merino G, Escámez T, Júdez J, Martínez S, Koenen KC, Navarro C, Alonso J, Kessler RC. Post-Traumatic Stress Disorder and other mental disorders in the general population after Lorca's earthquakes, 2011 (Murcia, Spain): A cross-sectional study. PLoS ONE 2017; 12(7): e0179690.
     
    Sánchez-González B*, ____________, Ferraro M, Calafell M, Gale C, Martinez L, Sancho E, García-Moreno P, Gimeno E, Garcia-Pallarols F, Salar A. Rituximab subcutaneous in B-cell non-Hodgkin lymphoma: clinical experience in a single center. Leukemia Lymphoma 2018; 59(4): 1019-1021.
     
    González-Gascón Y, Hernández-Sanchez M, Rodríguez-Vicente AE, Puiggros A, Collado R, Luño E, González T, Ruiz-Xivillé N, Ortega M, Gimeno E, Muñoz C, Infante MS, Delgado J, Vargas MT, González M, Bosch F, Espinet B, Hernández-Rivas JM, Hernández JÁ*, Grupo Español de Leucemia Linfática Crónica (GELLC) and Grupo Cooperativo Español de Citogenética Hematológica (GCECGH). Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia. Leukemia Lymphoma 2018; 59(3): 633-642.
     
    Ferrarini A, Righetti L, Martínez MP, Fernandez M, Mastrangelo A, Horcajada JP, Betbesé A, Esteban A, Ordóñez J, Gea J, Ruiz J, Pellati F, Lorente JA, Nin N, Rupérez FJ*. Discriminant Biomarkers of Acute Respiratory Distress Syndrome associated To H1n1 Influenza identified by metabolomics Hplc-Qtof-Ms/Ms platform. Electrophoresis 2017; 38(18): 2341-2348.
     
    Pérez V, Salavert A, Espadaler J, Tuson M, Saiz-Ruiz J, Sáez-Navarro C, Bobes J, Baca-García E, Vieta E, Olivares JM, Rodriguez-Jimenez R, Villagrán JM, Gascón J, Cañete-Crespillo J, Solé M, Saiz PA, Ibáñez Á, de Diego-Adeliño J, Menchón JM*, AB-GEN Collaborative Group. Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial. BMC Psychiatry 2017; 17: 250.
     
    Esquivel A, Matabosch X, Kotronoulas A, Balcells G, Joglar J, Ventura R*. Ionization and collision induced dissociation of steroid bisglucuronides. J Mass Spectrometry 2017; 52(11): 759-769.
     
    Magri G*, Comerma L, Pybus M, Sintes J, Lligé D, Segura D, Bascones S, Yeste A, Grasset EK, Gutzeit C, Uzzan M, Ramanujam M, van Zelm MC, Albero-González R, Vazquez I, Iglesias M, Serrano S, Marquez L, Mercade E, Mehandru S, Cerutti A*. Human Secretory IgM Emerges from Plasma Cells Clonally Related to Gut Memory B Cells and Targets Highly Diverse Commensals. Immunity 2017; 47: 118-134.
     
     
    Perera G, Pedersen L, Ansel D, Alexander M, Arrighi HM, Avillach P, Foskett N, Gini R, Gordon MF, Gungabissoon U, Mayer MA, Novak G, Rijnbeek P, Trifirò G, van der Lei J, Visser PJ, Stewart R*. Dementia prevalence and incidence in a federation of European Electronic Health Record databases-The European Medical Informatics Framework resource. Alzheimers Dement 2018; 14(2): 130-139.
     
    Guerra S*, Melén E, Sunyer J, Xu CJ, Lavi I, Benet M, Bustamante M, Carsin AE, Dobaño C, Guxens M, Tischer C, Vrijheid M, Kull I, Bergström A, Kumar A, Söderhäll C, Gehring U, Dijkstra DJ, van der Vlies P, Wickman M, Bousquet J, Postma DS, Antó JM, Koppelman GH. Genetic and epigenetic regulation of YKL-40 in childhood. J Allergy Clin Immunol 2018; 141(3): 1105-1114.
     
    Miquel J*, Fernández-Muñoz S, Santana F, Torrens C. Do we publish what we preach? Analysis of the European Society for Surgery of the Shoulder and Elbow Congress publication rates. J Orthop Surg 2017; 12: 119.
     
    Lopez-Aventin D, Jaka A, Masferrer E, Bernardez D, Pujol RM, Toll A. Mohs micrographic surgery using paraffin sections for the treatment of dermatofibroma of the face: A preliminary case series. Australas J Dermatol. 2017; 58(4): e264-e265.
     
    Oddi S*, Totaro A, Scipioni L, Dufrusine B, Stepniewski TM, Selent J, Maccarrone M*, Dainese E*. Role of palmitoylation of cysteine 415 in functional coupling CB1 receptor to G?i2 protein. Biotechnol Appl Bioc 2018; 65(1): 16-20.
     
    Sánchez MC*, Fàbregas-Escurriola M, Bergé D, Fernández-San Martín MI, Boreu QF, Goday A. Risk of underdiagnosis of hypertension in schizophrenia patients. Clin Exp Hypertens 2018; 40(2): 167-174.
     
    Zaragoza R*, Ferrer R, Llinares P, Maseda E, Rodríguez A, Grau S, Quindós G, EPICO Project Group.. ÉPICO 4.0. «Calidad total» en el manejo de la candidiasis invasiva en el paciente crítico mediante el análisis del proceso integrado. Rev Iberoam Micol 2017; 34(3): 143-157.
     
     
    Institut Hospital del Mar d'Investigacions Mèdiques
    Tel: 93 316 04 00
    Doctor Aiguader, 88
    08003 Barcelona
    Seguiu-nos a:
    Twitter
    Youtube
    En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
    Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).